ALT

Altimmune Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth 6/10
  • Value 0/10
Altimmune sales and earnings growth
ALT Growth
Good
  • Revenue Y/Y 42.10%
  • EPS Y/Y 26.98%
  • FCF Y/Y 10.78%
Altimmune gross and profit margin trends
ALT Profitability
Neutral
  • Gross margin 100.00%
  • EPS margin -253002.80%
  • ROIC 5Y -108.77%
Altimmune net debt vs free cash flow
ALT Risk
Great
  • Debt / Equity 0.1
  • Debt / FCF 0.0
  • Interest coverage -32.7

Altimmune stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks